PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 16, 2026Journal of Cancer Research and Clinical Oncology1 citationsOpen Access

The features and prognostic value of ARID1A mutation and protein expression in endometrial cancer of no specific molecular profile (NSMP) subtype: a retrospective study in a large Chinese cohort

XYXinhui YuanMCMengyuan CaiCYChangmin YU

Key Points

  • To evaluate the prognostic significance of ARID1A mutation and protein levels in endometrial cancer with no specific molecular profile.
  • Conducted a retrospective analysis in a large Chinese cohort.
  • Examined correlations between ARID1A mutation and protein expression.
  • Analyzed associations with ER/PR expression and PIK3CA mutation status.
  • ARID1A mutation linked to poorer progression-free survival for NSMP patients.
  • ARID1A protein expression correlated significantly with ARID1A mutation status.
  • Combined ARID1A mutation and other markers could refine classification of NSMP subtype.

Abstract

ARID1A mutation was associated with worse PFS for patients with NSMP. ARID1A protein expression was significantly associated with ARID1A mutation. ARID1A mutation, with ER/PR expression and PIK3CA mutation status, could serve as the potential biomarkers to subclassify NSMP subtype and provide more precise therapeutic target.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yuan et al. (2026) studied this question.

synapsesocial.com/papers/69b79df38166e15b153ab194https://doi.org/10.1007/s00432-026-06440-w
Ask AI
Helpful
Bookmark
Share
View Full Paper